Literature DB >> 1699871

Abundant expression of cytokeratin 7 in fibrolamellar carcinoma of the liver.

P Van Eyken1, R Sciot, P Brock, M Casteels-Van Daele, F C Ramaekers, V J Desmet.   

Abstract

Two cases of fibrolamellar carcinoma of the liver, one with lymph node metastasis are reported. Using immunohistochemistry as well as one- and two-dimensional gel electrophoresis and Western blotting, tumour cells of both primary lesions and of the metastasis were found to express cytokeratin polypeptides 8 and 18 and, surprisingly, cytokeratin 7. A small number of cells also expressed cytokeratin 19. This is the first detailed analysis of the cytokeratin expression of fibrolamellar carcinoma, and is also the first to present biochemical evidence that, contrary to what has been suggested, hepatocellular carcinomas do not always preserve the pattern of cytokeratin expression of normal hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1699871     DOI: 10.1111/j.1365-2559.1990.tb00679.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  11 in total

1.  The stem cells of the liver--a selective review.

Authors:  K Aterman
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

2.  Transcriptomic characterization of fibrolamellar hepatocellular carcinoma.

Authors:  Elana P Simon; Catherine A Freije; Benjamin A Farber; Gadi Lalazar; David G Darcy; Joshua N Honeyman; Rachel Chiaroni-Clarke; Brian D Dill; Henrik Molina; Umesh K Bhanot; Michael P La Quaglia; Brad R Rosenberg; Sanford M Simon
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-21       Impact factor: 11.205

3.  Genomic analysis of fibrolamellar hepatocellular carcinoma.

Authors:  Lei Xu; Florette K Hazard; Anne-Flore Zmoos; Nadine Jahchan; Hassan Chaib; Phillip M Garfin; Arun Rangaswami; Michael P Snyder; Julien Sage
Journal:  Hum Mol Genet       Date:  2014-08-13       Impact factor: 6.150

Review 4.  Histopathology of hepatocellular carcinoma.

Authors:  Manuel Schlageter; Luigi Maria Terracciano; Salvatore D'Angelo; Paolo Sorrentino
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

5.  Clinicopathological features and outcomes of fibrolamellar hepatocellular carcinoma.

Authors:  Sakti Chakrabarti; Sri Harsha Tella; Anuhya Kommalapati; Brandon M Huffman; Siddhartha Yadav; Irbaz Bin Riaz; Gaurav Goyal; Kabir Mody; Mitesh Borad; Sean Cleary; Rory L Smoot; Amit Mahipal
Journal:  J Gastrointest Oncol       Date:  2019-06

Review 6.  Re-Recognizing the Cellular Origin of the Primary Epithelial Tumors of the Liver.

Authors:  Jiliang Feng; Ruidong Zhu; Yu Yin; Shanshan Wang; Lei Zhou; Fudong Lv; Dawei Zhao
Journal:  J Hepatocell Carcinoma       Date:  2021-12-07

7.  Human liver organoids for disease modeling of fibrolamellar carcinoma.

Authors:  Nicole J C Narayan; David Requena; Gadi Lalazar; Lavoisier Ramos-Espiritu; Denise Ng; Solomon Levin; Bassem Shebl; Ruisi Wang; William J Hammond; James A Saltsman; Helmuth Gehart; Michael S Torbenson; Hans Clevers; Michael P LaQuaglia; Sanford M Simon
Journal:  Stem Cell Reports       Date:  2022-07-07       Impact factor: 7.294

Review 8.  Fibrolamellar carcinoma: 2012 update.

Authors:  Michael Torbenson
Journal:  Scientifica (Cairo)       Date:  2012-09-23

9.  Molecular testing for the clinical diagnosis of fibrolamellar carcinoma.

Authors:  Rondell P Graham; Matthew M Yeh; Dora Lam-Himlin; Lewis R Roberts; Luigi Terracciano; Michael W Cruise; Patricia T Greipp; Riyam T Zreik; Dhanpat Jain; Nida Zaid; Safia N Salaria; Long Jin; Xiaoke Wang; Jeanette G Rustin; Sarah E Kerr; William R Sukov; David A Solomon; Sanjay Kakar; Emily Waterhouse; Ryan M Gill; Linda Ferrell; Venancio Af Alves; Deniz Nart; Funda Yilmaz; Stephanie Roessler; Thomas Longerich; Peter Schirmacher; Michael S Torbenson
Journal:  Mod Pathol       Date:  2017-09-01       Impact factor: 7.842

10.  iTRAQ-Based Quantitative Proteomic Analysis of the Inhibitory Effects of Polysaccharides from Viscum coloratum (Kom.) Nakai on HepG2 Cells.

Authors:  Yangyang Chai; Min Zhao
Journal:  Sci Rep       Date:  2017-07-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.